(Q54385556)
Statements
A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma. (English)
Benoit You
Christophe Le Tourneau
Eric X Chen
Lisa Wang
Andrea Jarvi
Rikki R Bharadwaj
Vijay Mann
Lillian L Siu
1 June 2012
35
3
255-260